Recently, we have conducted an in-depth observation of the 2023 Autumn Ranking of the Alibi Hospital Competition Group. Among the top 20 private hospital groups, the headquarters of the leading medical groups are basically in first-tier cities, with half of them in Beijing, Shanghai and Guangzhou. In addition to Aier Ophthalmology, other medical groups are mainly located in general hospitals, and most of the group hospitals are below ** hospitals. There are 7 ophthalmic medical groups in the top 100 and 2 dental medical groups, and the second-class hospitals have a high rate of being out of the circle. There are also some pharmaceutical companies that have invested in local hospitals, and some of them are well-known restructured hospitals.
Among them, Aier Ophthalmology, China Resources Medical, and Fosun Health ranked in the top three, and Aier Ophthalmology improved from the second place last year to the first place this year. We have listed the service volume, leading disciplines, staff and bed allocation of the top three medical groups as follows:
1.Aier Ophthalmology.
Founded in 2002, Aier Ophthalmology has a medical network in Asia, Europe and North America, and was listed in Shenzhen, China in 2009. As of December 31, 2023, there are 875 Aier Eye Hospitals, Eye Centers and Clinics worldwide. Among them, 744 are in Chinese mainland, 8 are in Hong Kong, China, and more than 123 ophthalmology clinics are deployed overseas, including 1 in the United States, 108 in Europe, and 14 in Southeast Asia. In 2022, the group's business revenue will be 16.1 billion yuan, and the operating profit will be 353.4 billion yuan.
2.China Resources Medical.
China Resources Healthcare Holdings*** (hereinafter referred to as "China Resources Healthcare") is a leading comprehensive medical listed company in the capital markets of Mainland China and Hong Kong, and the only listing platform of China Resources Health Group, a wholly-owned subsidiary of China Resources Group. At present, there are 146 medical institutions, including 13 first-class hospitals and 27 secondary hospitals, with a total of 21,985 operating beds, covering 10 provinces (autonomous regions and municipalities). In 2022, the annual outpatient volume of its member hospitals increased by 21%;Hospitalizations increased by 1 year-on-year5%。From the perspective of business caliber, the annual medical business revenue of its member hospitals reached a total of 833.6 billion yuan, a slight increase of 08%。
3.Fosun Health.
Founded in 2010, Fosun Health is a holding subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and as of the end of June 2023, Fosun Health has obtained a total of 9 Internet hospital licenses, with a total of 6,448 approved beds in the holding hospitals.